Novel medicine prescription payer rejection rate

Average percentage of first-year prescriptions for newly launched medicines rejected by insurance payers.

Unit Percent Industry Pharmaceuticals

Records
1
Regions
1
Period
2020–2024
Sources
1
Verification 1 verified data points Updated 17 Sep 2026 Last verified 17 Sep 2026 Next update Sources typically refresh annually

The chart

The figure

One published observation so far. A chart follows as soon as a second period is published.

Novel medicine prescription payer rejection rate

United States, 2020–2024

1 observation
49% United States · 2020–2024 · IQVIA · full record
Source: IQVIA · CC BY 4.0 · statorigin.org

Every record

All records

1 record · 1 region · 2020–2024

Novel medicine prescription payer rejection rate: every record, grouped by region, newest first.
Period Value Source Type
United States 1 record
2020–2024 49% IQVIA · 31 Dec 2024 actual

Primary documents

Sources

1 document. Each links to the publisher's own copy.

Document Publisher Published Data points
U.S. Medicine Use Trends 2026 IQVIA 1

Cite & reuse

Cite this page

Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.

StatOrigin. (2026). Novel medicine prescription payer rejection rate. Retrieved from https://statorigin.org/indicators/novel-medicine-prescription-payer-rejection-rate